DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Amgen (AMGN) Announces 2015 Second Quarter Dividend 3/5/2015 9:53:01 AM
Amgen (AMGN) Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 3/3/2015 9:01:57 AM
Amgen (AMGN) Announces Launch Of New Neulasta (Pegfilgrastim) Delivery Kit 3/3/2015 6:48:04 AM
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences 3/3/2015 6:41:12 AM
Amgen (AMGN) Release: Phase 3 Head-To-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis (Carfilzomib) Over Velcade (Bortezomib) In Patients With Relapsed Multiple Myeloma 3/2/2015 6:42:03 AM
New Jersey Startup Celimmune Aims to Give New Life to Shelved Amgen (AMGN) Drug 3/2/2015 6:31:48 AM
Amgen (AMGN) Receives Positive CHMP Opinion For Use Of Vectibix (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Advanced Colorectal Cancer 2/27/2015 9:33:46 AM
Amgen (AMGN) Announces The European Medicines Agency Acceptance Of Kyprolis (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma 2/27/2015 6:49:51 AM
Amgen (AMGN) To Present At The Cowen and Company 35th Annual Health Care Conference 2/26/2015 9:35:04 AM
Amgen (AMGN)'s Hormone-Imbalance Drug AMG 416 Shows Positive Results in Phase 3 Study 2/26/2015 6:27:39 AM
12345678910...